have a new treatment option that combines olopatadine hydrochloride and mometasone furoate in the form of a nasal spray. Ryaltris (Hikma Pharmaceuticals PLC and Glenmark Pharmaceuticals Ltd ...

Ryaltris combines olopatadine hydrochloride and mometasone furoate in a single nasal spray. The FDA approved the spray in January to treat ocular and nasal seasonal allergic rhinitis symptoms in ...

Olopatadine ophthalmic solution (eye drops) is available as a brand-name drug and as a generic drug. Brand name: Pataday. Olopatadine comes as eye drops and as a nasal spray. Olopatadine eye drops ...

The recommended dosage is two sprays per nostril twice daily. Children 6 to 11 years of age: The recommended dosage is one spray per nostril twice daily.

Oxymetazoline hydrochloride (Afrin ... Side effects can include headache, sore throat, nosebleed, or cough. This nasal spray prevents your body from releasing histamines, chemicals that cause ...

Hikma will continue producing its 8 mg naloxone HCl nasal spray in its Columbus, Ohio manufacturing facility and will provide it to Emergent as its exclusive commercial partner. "We are thrilled ...

Hikma and Glenmark Specialty are introducing Ryaltris (olopatadine hydrochloride and mometasone furoate nasal spray). Ryaltris is used for the treatment of symptoms of seasonal allergic rhinitis ...

is recalling 45,504 bottles of Ryaltris (olopatadine hydrochloride and mometasone fluorate) Nasal Spray. The company is recalling the affected lot due to "defective delivery system", the US Food ...

Narcan, a 4-milligram naloxone hydrochloride nasal spray, will not require a prescription and will be available in supermarkets, convenience and drug stores, gas stations, vending machines and online.